Lumicks introduces novel C-Trap product at Biophysical Society annual meeting
Lumicks has introduced a new innovative C-Trap to its portfolio at the 66th Annual Biophysical Society Meeting in San Francisco, California. Lumicks will also rebrand its existing flagship C-Trap product line into C–Trap Dymo. Read More
PharmaCyte Biotech announces results on cytochrome P450 gene
PharmaCyte Biotech has shown an additional, more finely detailed, analysis of the integration site of the cytochrome P450 2B1 gene from the augmented HEK293 cell clone that is used in PharmaCyte’s pancreatic cancer product candidate known as CypCaps. Read More
Element Biosciences partners with Agilent Technologies
Element Biosciences has partnered with Agilent Technologies to demonstrate the integration of Element’s AVITI System with Agilent Technologies’ industry-leading SureSelect target enrichment panels, providing customers greater access to these genomic tools. Read More
NORD grades all 50 states on rare disease policy issues
The National Organization for Rare Disorders (NORD) published the latest edition of its annual State Report Card, which rates all 50 states and Washington, D.C., on the most important issues affecting the more than 25 million Americans living with a rare disease. Read More
Dante Labs partners with Renato Dulbecco Foundation
Dante Labs is partnering with the Renato Dulbecco Foundation to deliver more personalized therapies in rare diseases, oncology, and COVID-19. Read More
Program launches to grow new life science startups in Colo.
Innosphere Ventures, the Colorado BioScience Association, and the Colorado BioScience Institute announced their plan to launch a comprehensive incubator program for life science startups with support from the state of Colorado. Read More
Automata raises $50M to accelerate automation in life sciences
Automata announced it has raised $50 million in series B funding to help life sciences rapidly innovate, diagnose, and discover at scale. The investment will enable significant development of Automata Labs for scientists working across diagnostic, drug discovery, and biotech in the U.K. and beyond. Read More
Lilly establishes Institute for Genetic Medicine, invests in Boston Seaport site
Eli Lilly has launched the Lilly Institute for Genetic Medicine and invested approximately $700 million to establish a state-of-the-art facility at a new site in the Boston Seaport district. This investment falls in line with the company's strategy to advance RNA-based therapeutics. Read More
Code Bio partners with Takeda to develop rare disease gene therapies
Code Biotherapeutics has entered into a collaboration and option agreement with Takeda to leverage Code Bio's proprietary targeted 3DNA nonviral genetic medicine delivery platform to design and develop gene therapies for rare disease indications. Read More
Remix Therapeutics enters collaboration with Janssen
Remix Therapeutics is collaborating with Janssen Pharmaceutica, one of the Janssen Pharmaceutical companies of Johnson & Johnson, for the discovery and development of small molecule therapeutics that modulate RNA processing using Remix's REMaster drug discovery platform. Read More
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Connect
